New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2013
10:53 EDTITMN, BIG, WCG, FISV, KSUHigh option volume stocks: ITMN BIG WCG FISV KSU
News For ITMN;BIG;WCG;FISV;KSU From The Last 14 Days
Check below for free stories on ITMN;BIG;WCG;FISV;KSU the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 21, 2014
05:22 EDTITMNInterMune downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded InterMune to Market Perform citing valuation.
August 20, 2014
05:53 EDTITMNStocks with implied volatility movement; NGD ITMN
Subscribe for More Information
August 18, 2014
10:01 EDTWCGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:46 EDTWCGWellCare downgraded at Wedbush
As noted earlier, Wedbush downgraded WellCare to Neutral from Outperform. The firm no longer sees the company as a takeover candidate, and it thinks that the company will need at least 2-3 years to turn itself around. Target to $55 from $70.
07:22 EDTWCGWellCare downgraded to Neutral from Outperform at Wedbush
Subscribe for More Information
August 14, 2014
16:11 EDTWCGWellCare expects to appoint Andrew Asher as CFO in November
Subscribe for More Information
10:05 EDTITMNOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Adidas (ADDYY) downgraded to Neutral from Buy at Goldman... Fabrinet (FN) downgraded at B. Riley... Freeport McMoRan (FCX) downgraded at Stifel... Infosys (INFY) downgraded to Hold from Buy at Jefferies... InterMune (ITMN) downgraded to Neutral from Buy at Goldman... Jones Energy (JONE) downgraded to Neutral from Overweight at JPMorgan... LVMH Moet Hennessy (LVMUY) downgraded to Neutral from Buy at Goldman... Madison Square Garden (MSG) downgraded to Hold from Buy at Topeka... Qualys (QLYS) downgraded to Sector Perform from Outperform at RBC Capital... SeaWorld (SEAS) downgraded to Market Perform from Outperform at Wells Fargo... Theravance Biopharma (TBPH) downgraded to Underperform from Neutral at RW Baird... URS Corporation (URS) downgraded to Neutral from Buy at Sterne Agee... ViaSat (VSAT) downgraded to Perform from Outperform at Oppenheimer... Wynn Resorts (WYNN) downgraded to Hold from Buy at Gabelli.
09:11 EDTITMNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Kohl's (KSS), up 2.5%... Plug Power (PLUG), up 10%... Perrigo (PRGO), up 4.5%. HIGHER: Aruba Networks (ARUN), up 3% after shares upgraded at Stifel... KaloBios (KBIO), up 7.9% after publication shows EphA3 as target for anticancer therapy... Supernus (SUPN), up 4.4% after receiving FDA fast track designation for SPN-810. DOWN AFTER EARNINGS: Noodles & Company (NDLS), down 22%... Vipshop (VIPS), down 5.8%. LOWER: ExOne (XONE), down 10.7%, Voxeljet (VJET), down 6.6%, after earnings reports. Peers in the 3D space are lower as well, with Stratasys (SSYS) down 1% and 3D Systems (DDD) down 0.2%... Enphase Energy (ENPH), down 2.6% after filing to sell common stock for holders... InterMune (ITMN), down 3% after downgraded at Goldman following yesterday's advance on Bloomberg report that the company received takeover bids from Sanofi (SNY), Roche (RHHBY).
05:28 EDTITMNInterMune downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded InterMune (ITMN) to Neutral citing valuation after the stock rallied on a Bloomberg report of takeover interest. Goldman continues to expect InterMune's Esbriet for orphan lung disease will receive FDA approval on or before the November 23 action date. The firm has a $49 price target for shares, which closed yesterday up 14% to $52.06.
August 13, 2014
16:19 EDTITMNOn The Fly: Closing Wrap
Subscribe for More Information
13:29 EDTITMNInterMune options active after Bloomberg report of takeover bids
Subscribe for More Information
13:13 EDTITMNInterMune exploring sale after bids from Sanofi, Roche, Glaxo, Bloomberg says
InterMune (ITMN) is working with its financial advisers Goldman Sachs (GS) and Centerview Partners to evaluate takeover bids it has received from Sanofi (SNY), Roche (RHHBY), GlaxoSmithKline (GSK) and Actelion (ALIOF), said Bloomberg, citing people with knowledge of the matter. The report noted that one of the sources said Sanofi has so far shown the most interest in a deal for InterMune, whose shares are up more than 13% to $51.56 following the first headlines from the report. Reference Link
13:02 EDTITMNInterMune jumps 20% to $54.57 after Bloomberg report of takeover bids
Subscribe for More Information
13:01 EDTITMNInterMune working with banks on sale after bids, Bloomberg reports
Subscribe for More Information
13:00 EDTITMNInterMune received takeover bids from Sanofi, Roche, Bloomberg says
August 12, 2014
10:00 EDTKSUOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:32 EDTKSUKansas City Southern upgraded at Macquarie
As previously reported, Macquarie upgraded Kansas City Southern to Neutral from Underperform. The firm upgraded shares based on heavy crude start-ups in Baton Rouge and Beaumont and ethylene project updates to drive growth. Price target raised to $114 from $106.
07:56 EDTKSUKansas City Southern upgraded to Neutral from Underperform at Macquarie
August 11, 2014
15:23 EDTITMNInterMune rumored to be working with adviser to explore options, Betaville says
Subscribe for More Information
15:22 EDTITMNInterMune August volatility increases on wide price movement
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use